Carvedilol Tablet, Film Coated
Product Images NDC 68462-162

11 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68462-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol-chemical-structure (Structure)

Carvedilol-chemical-structure (Structure)
Chemical structure of Carvedilol, displaying its molecular arrangement including aromatic rings, hydroxyl group, ether linkages, and amino groups as shown in the diagram.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line chart comparing percent mortality over 21 months between Placebo and Carvedilol groups. The graph shows mortality increasing over time, with the Carvedilol group having a lower mortality rate than the Placebo group. A P value of 0.0014 is indicated, suggesting statistical significance.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A forest plot showing hazard ratios with confidence intervals for various subgroups including sex, age, race, diabetes status, ischemic conditions, heart rate, systolic blood pressure, spironolactone use, and overall patients. The x-axis represents hazard ratio values ranging from 0.0 to 2.0, with a vertical line at 1.0 for reference.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A survival analysis graph titled 'Survival Analysis for CAPRICORN (intent-to-treat)' showing percentage mortality over 24 months. The graph compares two lines representing mortality rates for placebo and Carvedilol groups, with the Carvedilol group showing lower mortality. The p-value is 0.03, indicating statistical significance.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A forest plot titled 'Figure 4. Effects on Mortality for Subgroups in CAPRICORN' showing hazard ratios for various patient subgroups. The x-axis represents hazard ratios from 0.4 to 1.3, with vertical lines at 0.7, 1.0, and 1.3. Two columns of subgroup comparisons are displayed, including age, gender, timing of randomization post-MI, prior beta-blocker use, Killip classification, thrombolytic therapy, PTCA for MI, heart failure history, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Each subgroup is marked with black circles and confidence intervals, illustrating the effect of treatment on mortality risk within these subgroups.*
FDA Label Image

Logo1 (Logo1)

FDA Label Image
FDA Label Image

Label3125mg100s (Label3125mg100s)

Label3125mg100s (Label3125mg100s)
Label for Carvedilol Tablets, USP 3.125 mg film-coated tablets by Glenmark Pharmaceuticals Inc., USA. The label shows the NDC 68462-162-01, package contains 100 tablets, and indicates prescription use only. Storage and packaging instructions along with distributor details and contact information are also visible.*
FDA Label Image

Label625mg100s (Label625mg100s)

Label625mg100s (Label625mg100s)
Carvedilol Tablets, USP 6.25 mg film-coated tablets. The label shows a 100-tablet prescription container distributed by Glenmark Pharmaceuticals Inc., USA. It includes storage instructions and a barcode on the right side.*
FDA Label Image

Label125mg100s (Label125mg100s)

Label125mg100s (Label125mg100s)
Carvedilol Tablets USP 12.5 mg film-coated tablets label from Glenmark Pharmaceuticals Inc., USA. The label specifies a package size of 100 tablets and includes storage instructions and distributor information. It features the NDC code 68462-164-01 and contact details for the manufacturer.*
FDA Label Image

Label25mg100s (Label25mg100s)

Label25mg100s (Label25mg100s)
Label for Carvedilol Tablets, USP 25 mg by Glenmark Pharmaceuticals Inc., USA. The film-coated oral tablet packaging shows 100 tablets labeled Rx only, with product information including dosage, storage instructions, and contact information. The NDC number 68462-165-01 appears near the top left and barcode is on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.